BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.

Otros idiomas Beijing Aosaikang Pharmaceutical Co., Ltd.

Acciones

002755

CNE100001X92

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
9,8 ^CNY	+0,41 %		+14,75 %	-9,43 %

05/03	La unidad de Beijing Aosaikang Pharma obtiene el visto bueno para comercializar delafloxacina inyectable	MT
23/01	Aosaikang Pharmaceutical registra un fármaco contra el cáncer de mama	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Beijing Aosaikang Pharma's Unit Gets Nod to Market Delafloxacin for Injection	05/03
Aosaikang Pharmaceutical Registers Breast Cancer Drug	23/01
Aosaikang Pharmaceutical's Unit Gets Nod for Two Drugs	17/01
Aosaikang Pharmaceutical's Unit Gets Nod to Trial ASKC202 Tablets	13/11
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Aosaikang Pharmaceutical's Unit Gets Nod to Test Gastric Cancer Drug	17/10/23
Beijing Aosaikang Pharmaceutical Co., Ltd.(XSEC:002755) added to S&P Global BMI Index	18/09/23
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
Aosaikang Pharma's Unit Gets Nod to Amend Instructions for Heart Drug	07/08/23
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23
Aosaikang Pharma Unit Registers Acid Reflux Drug in China	17/04/23
Aosaikang Pharma Registers Three Drugs	24/03/23
Aosaikang Pharma US Unit Gets Regulatory Nod For Anti-Tumor Drug Trial	20/12/22
Beijing Aosaikang Pharmaceutical Co., Ltd.(XSEC:002755) dropped from S&P Global BMI Index	19/12/22
Aosaikang Pharma Wins Nod to Market Variant of Pfizer’s Breast Cancer Drug	21/11/22
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	28/08/22
Beijing Aosaikang Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2021, Payable on June 20, 2022	10/06/22
Beijing Aosaikang Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021	23/05/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Beijing Aosaikang Pharmaceutical Co., Ltd.

Acciones

002755

CNE100001X92

Otros idiomas

Filtros